Trending Topics

 

Check out the latest cancer-related news and also see who is readily available to offer reliable information, expert commentary, and reaction to today's headlines.
Contact a media coordinator

The 2016 ASTRO Annual Meeting will take place in Boston from September 25 to 28. Featuring new insights and discoveries from leading institutions around the world, this scientific forum will include presentations and data that could affect the way cancer care is planned and delivered. Memorial Sloan Kettering radiation oncologists are available to comment on meeting news and presentations. Follow the meeting live on Twitter using the hashtag #ASTRO16. For more information or to speak with an expert, contact mediastaff@mskcc.org.
Friday, September 23, 2016
 
A new drug is being shown to extend the lives of patients with advanced soft tissue sarcoma by almost a year. The results of a multicenter phase II trial evaluating the efficacy and safety of olaratumab in combination with doxorubicin chemotherapy was published in The Lancet on June 9. William Tap, MD, Chief of the Sarcoma Medical Oncology Service at Memorial Sloan Kettering Cancer Center (MSK), served as corresponding author on this study, which met its primary endpoint of progression-free survival and showed a statistically significant improvement in overall survival. To arrange an interview with Dr. Tap, please email mcnamarn@mskcc.org.
Friday, June 10, 2016
 
MSK researchers are presenting nearly 120 studies at the 2016 Annual Meeting of the American Society of Clinical Oncology.
Friday, June 3, 2016
 
See all trending topics
 

Press Releases

 
Memorial Sloan Kettering and Hackensack Meridian Health announced the Memorial Sloan Kettering–Hackensack Meridian Health partnership, a joint venture that will combine both organizations’ unparalleled expertise in all areas of cancer care and research to accelerate new discoveries and improve the lives of patients they jointly serve.
Wednesday, December 14, 2016
 
Nearly 20 years have passed since Memorial Sloan Kettering Cancer Center (MSK) first opened its doors in the Garden State. Since then, an explosion of knowledge and data has resulted in far better outcomes for thousands of people with cancer, including many who’ve sought care at MSK’s facility in New Jersey.
Monday, November 28, 2016
 
Memorial Sloan Kettering Cancer Center (MSK), The Rockefeller University and Weill Cornell Medicine announced today that they have established a new drug discovery company called Bridge Medicines. Launched in partnership with Takeda Pharmaceutical Company Ltd. and healthcare investment firms Bay City Capital and Deerfield Management, Bridge Medicines is a groundbreaking initiative that completes a seamless, fully funded and professionally staffed path from concept to drug candidate to efficiently and rapidly develop innovative therapeutics for treating human diseases.
Monday, October 31, 2016
 
See all press releases
 

On Our Blog

 
IN THE CLINIC
Two MSK experts explore why more people at risk are not undergoing screening for lung cancer.
Friday, January 20, 2017
 
FINDING
New research of metastatic pancreatic cancer has shown that the same mutations are involved in driving both the primary tumor and the metastases.
Tuesday, January 17, 2017
 
IN THE CLINIC
MSK now offers interventional radiology consultations as well as many procedures at three of its outpatient locations.
Thursday, January 12, 2017
 
See all blog posts
 

Media Coverage

 
President and CEO Craig Thompson was interviewed about Memorial Sloan Kettering’s partnership with Hackensack Meridian Health.  
Wednesday, December 28, 2016
 
Medical oncologist Jae Park discusses new research that looks at how CAR-T therapy is making progress in treating brain cancer. 
Wednesday, December 28, 2016
 
Medical oncologists Robert Motzer and Alexander Lesokhin were interviewed for a special feature in The New York Times about minorities and clinical trials. 
Friday, December 23, 2016
 
See all media coverage
 

If you wish to contact MSK about a marketing or advertising related opportunity, or are looking for additional information about our ad campaign, please email us at marketing@mskcc.org.

For Journalists

Jeanne D'Agostino
Director, Media and Public Relations
 
Emily O'Donnell
Senior Communications Associate, Department of Surgery
 
Courtney Nowak
Senior Media Relations Associate
 
Caitlin Hool
Senior Media Associate
 
Nicole H. McNamara
Senior Media Relations Associate
 
Rebecca Williams
Media Associate
 
For press inquiries, our Media Staff are available by calling 646-227-3573 or by dialing the numbers above. Our office hours are Monday - Friday, 9:00 AM to 5:00 PM.
 
After hours, please contact the hospital's page operator at 212-639-7900 and ask for the Public Affairs representative on-call.

Live and Remote Broadcast Capabilities

Our experts can offer live broadcast interviews using the on-site studio system. To book an expert interview using our on-site broadcast studio contact our Media Staff.

News@MSKCC

Get the latest information from our media staff on advances in research at MSK.

Newsletter Sign Up Unsubscribe